Search Results - "Rosemarie B. Lichtner"

Refine Results
  1. 1

    Total Synthesis and Antitumor Activity of ZK-EPO: The First Fully Synthetic Epothilone in Clinical Development by Klar, Ulrich, Buchmann, Bernd, Schwede, Wolfgang, Skuballa, Werner, Hoffmann, Jens, Lichtner, Rosemarie B.

    Published in Angewandte Chemie International Edition (04-12-2006)
    “…Going to trial: From about 350 active epothilone analogues synthesized by a highly convergent synthesis, one (ZK‐EPO, see picture) has been chosen for clinical…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Studies on the development of resistance to the pure antiestrogen Faslodex™ in three human breast cancer cell lines by Sommer, Anette, Hoffmann, Jens, Lichtner, Rosemarie B., Schneider, Martin R., Parczyk, Karsten

    “…In order to understand the mechanisms underlying the development of resistance to a pure antiestrogen we established three human breast carcinoma cell lines…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Towards the validation of a lung tumorigenesis model with mainstream cigarette smoke inhalation using the A/J mouse by Stinn, Walter, Berges, An, Meurrens, Kris, Buettner, Ansgar, Gebel, Stephan, Lichtner, Rosemarie B, Janssens, Kris, Veljkovic, Emilija, Xiang, Yang, Roemer, Ewald, Haussmann, Hans-Juergen

    Published in Toxicology (Amsterdam) (08-03-2013)
    “…Highlights ► Reliability of the assay was shown by intra- and inter-laboratory reproducibility. ► Robustness was shown by comparison to historic data. ►…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors by LICHTNER, Rosemarie B, MENRAD, Andreas, SOMMER, Anette, KLAR, Ulrich, SCHNEIDER, Martin R

    Published in Cancer research (Chicago, Ill.) (01-08-2001)
    “…Several inhibitors of EGF receptor (EGFR) tyrosine kinase activity have been developed that compete with ATP at its binding site such as the quinazolines PD…”
    Get full text
    Journal Article
  10. 10

    Estrogen/EGF receptor interactions in breast cancer: rationale for new therapeutic combination strategies by Lichtner, Rosemarie B.

    Published in Biomedicine & pharmacotherapy (01-12-2003)
    “…In the therapy of estrogen receptor (ER) positive human mammary carcinomas, the treatment with the antiestrogen tamoxifen has been well established. However,…”
    Get full text
    Journal Article
  11. 11
  12. 12

    EGF receptor targeting in therapy-resistant human tumors by Schmidt, Mathias, Lichtner, Rosemarie B

    Published in Drug resistance updates (01-02-2002)
    “…The development of resistance against cytotoxic or endocrine therapy limits the number of chemotherapeutic compounds used in the clinic. The receptor for EGF…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Cellular distribution and biological activity of epidermal growth factor receptors in A431 cells are influenced by cell-cell contact by Lichtner, R B, Schirrmacher, V

    Published in Journal of cellular physiology (01-08-1990)
    “…The potential significance of cell-cell interactions on EGF receptor (EGFR) activity was investigated in cultured adherent A431 cells seeded as single-cell…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Cover Picture: Total Synthesis and Antitumor Activity of ZK-EPO: The First Fully Synthetic Epothilone in Clinical Development (Angew. Chem. Int. Ed. 47/2006) by Klar, Ulrich, Buchmann, Bernd, Schwede, Wolfgang, Skuballa, Werner, Hoffmann, Jens, Lichtner, Rosemarie B.

    Published in Angewandte Chemie International Edition (04-12-2006)
    “…Nature is a brilliant architect for the design of compounds with interesting biological functions. Epothilone B (top), a metabolite of myxobacteria (fruiting…”
    Get full text
    Journal Article
  17. 17
  18. 18

    EGF receptor in neoplasia and metastasis by Khazaie, K, Schirrmacher, V, Lichtner, R B

    Published in Cancer and metastasis reviews (01-09-1993)
    “…EGFR is a member of the tyrosine kinase family of cell surface receptors with a wide range of expression throughout development and in a variety of different…”
    Get full text
    Journal Article
  19. 19
  20. 20